Clinical Trial Update: Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of ST-1898 for locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma

Drugs mentioned

• ST-1898

Snippet

Sponsor: Beijing Scitech-Mq Pharmaceuticals Limited | Conditions: Differentiated Thyroid Carcinoma | Phase 2 | Status: RECRUITING